![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Rucaparib Explored for High-Risk Ovarian Cancer (Targeted Oncology) View |
![]() |
Outlook for Patients With High-Risk Ovarian Cancer (Targeted Oncology) View |
![]() |
Defining Rucaparib’s Value in Recurrent Ovarian Cancer (Targeted Oncology) View |
![]() |
Efficacy and Safety of Rucaparib: A Focus on ARIEL3 (AJMCtv) View |
![]() |
Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian Cancer (European Society for Medical Oncology (ESMO)) View |
![]() |
ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients (ecancer) View |
![]() |
PARP Inhibitors in Recurrent Ovarian Cancer (OncLive) View |
![]() |
Ovarian Cancer: Genetic Testing and Familial Risk (curetoday) View |
![]() |
Current Landscape of PARP Inhibition in Ovarian Cancer (Targeted Oncology) View |
![]() |
Maintenance Therapy for Advanced Ovarian Cancer (Targeted Oncology) View |